Showing results (611-620 of 902) with videos related to
Sort By:
Pageof 91
Case Reports in Neurology|June 30, 2020
Probable Creutzfeldt-Jakob Disease Presenting Dementia and Urinary RetentionYosuke Aiba, Ryuji Sakakibara, Ayako Iimura, et al.Clinical Neurophysiology Practice|February 24, 2026
Effective connectivity between homologous cortices mediated by the corpus callosum: An axono-cortical evoked potentials studyTakumi Mitsuhashi, Yasushi Iimura, Hiroharu Suzuki, et al.Scientific Reports|January 17, 2015
Superconductivity at 52 K in hydrogen-substituted LaFeAsO(1-x)Hx under high pressureH Takahashi, H Soeda, M Nukii, et al.Endocrinologia Japonica|October 1, 1984
A simple and sensitive method for determination of human urinary kallikrein activity (kininogenase activity), using human low molecular weight kininogenM Kondo, K Shimamoto, N Ura, et al.Toxicology in Vitro : an International Journal Published in Association with BIBRA|July 27, 2010
Interlaboratory validation of in vitro eye irritation tests for cosmetic ingredients. (2) Chorioallantoic membrane (CAM) testS Hagino, S Kinoshita, N Tani, et al.Bioorganic & Medicinal Chemistry Letters|August 3, 2010
Discovery of imidazo[1,2-b]pyridazine derivatives as IKKbeta inhibitors. Part 1: Hit-to-lead study and structure-activity relationshipHiroki Shimizu, Shinji Tanaka, Tadashi Toki, et al.Cancer Science|October 27, 2010
Phase-II trial of combination treatment of interferon-α, cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor (I-CCA therapy) for advanced renal cell carcinomaManabu Tatokoro, Yasuhisa Fujii, Satoru Kawakami, et al.Molecular & General Genetics : MGG|March 26, 1997
A novel yeast gene, RHK1, is involved in the synthesis of the cell wall receptor for the HM-1 killer toxin that inhibits beta-1,3-glucan synthesisT Kimura, N Kitamoto, Y Kito, et al.Cytokine|August 30, 2003
Proinflammatory effects of exogenously administered IL-10 in experimental autoimmune orchitisTetsushi Kaneko, Masahiro Itoh, Yoichi Nakamura, et al.Nihon Jinzo Gakkai Shi|September 26, 2003
[Additive antiproteinuric effect of angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor in patients with chronic glomerulonephritis]Osamu Iimura, Eiji Kusano, Kaichiro Tanba, et al.Pageof 91